We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Problem-Solving Strategy Depends on Estrogen Levels

By Biotechdaily staff writers
Posted on 09 Jun 2002
Investigators have found that activation of different parts of the brain may depend on the presence or absence of estrogen. More...
A study on the effect of the hormone or its lack on rat learning behavior appears in the June 2002 issue of Behavioral Neuroscience.

Results from previous studies on rats were difficult to interpret, as the rats were forced to cope with stress as well as learn new tasks. The current studies were carried out using positive-reward, food-based tests in order to remove stress from the equation.

Two different types of tasks were studied: a place-learning task, where the food was always in the same place, and a response-learning task, where a new route to the food had to be learned. The ovaries were removed from the rats to decrease circulating estrogen levels. One group then had estrogen levels raised by injections of the hormone.

In the place-training test, food always was at the same place, but the required turn in the maze changed, depending on the rats' starting point. Rats on estrogen learned the task faster than the untreated group. For the response-training test, the rats always found food by turning right (or left) at the first opportunity regardless of where they had started. Rats without estrogen learned this task quicker than the estrogen-treated ones.

"What we found is that given these analogous tasks that require different cognitive strategies, estrogen biased the rats to use a place, or spatial, strategy,” said Dr. Donna L. Korol, of the University of Illinois (Urbana-Champaign, USA). "Those not given estrogen are better using a response, or non-spatial, strategy. This suggests that estrogen is not good for all kinds of memory. Rather, it is very specific in dictating what strategy one takes. Estrogen may enhance some and impair other forms of learning.”

The researchers extrapolated their findings in rats to suggest that they may mimic the situation in postmenopausal women. "A postmenopausal woman not on HRT [hormone replacement therapy] may believe that her ability to solve a problem as she always had is slipping. In reality, the brain may be shifting gears into a different strategy that the woman is not used to harnessing,” Korol said.



Related Links:
University of Illinois

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.